Reisa A. Sperling

112.9k total citations · 28 hit papers
534 papers, 41.5k citations indexed

About

Reisa A. Sperling is a scholar working on Psychiatry and Mental health, Physiology and Cognitive Neuroscience. According to data from OpenAlex, Reisa A. Sperling has authored 534 papers receiving a total of 41.5k indexed citations (citations by other indexed papers that have themselves been cited), including 368 papers in Psychiatry and Mental health, 252 papers in Physiology and 196 papers in Cognitive Neuroscience. Recurrent topics in Reisa A. Sperling's work include Dementia and Cognitive Impairment Research (361 papers), Alzheimer's disease research and treatments (243 papers) and Functional Brain Connectivity Studies (158 papers). Reisa A. Sperling is often cited by papers focused on Dementia and Cognitive Impairment Research (361 papers), Alzheimer's disease research and treatments (243 papers) and Functional Brain Connectivity Studies (158 papers). Reisa A. Sperling collaborates with scholars based in United States, Australia and Netherlands. Reisa A. Sperling's co-authors include Keith A. Johnson, Dorene M. Rentz, Trey Hedden, Bradford C. Dickerson, Gad A. Marshall, Aaron P. Schultz, Rebecca E. Amariglio, Clifford R. Jack, Elizabeth C. Mormino and Randy L. Buckner and has published in prestigious journals such as New England Journal of Medicine, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Reisa A. Sperling

514 papers receiving 40.8k citations

Hit Papers

Cortical Hubs Revealed by... 2005 2026 2012 2019 2009 2011 2015 2016 2009 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cortical Hubs Revealed by Intrinsic Functional Connectivity: Mapping, Assessment of Stability, and Relation to Alzheimer's Disease
    2009 2.3k citations Randy L. Buckner, Jorge Sepulcre et al. Journal of Neuroscience profile →
  2. Introduction to the recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
    2011 1.3k citations Reisa A. Sperling, María C. Carrillo et al. Alzheimer s & Dementia profile →
  3. Alzheimer's disease
    2015 1.3k citations Kaj Blennow, Reisa A. Sperling et al. profile →
  4. A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
    2016 1.2k citations David A. Bennett, Kaj Blennow et al. Neurology profile →
  5. Amyloid Deposition Is Associated with Impaired Default Network Function in Older Persons without Dementia
    2009 777 citations Reisa A. Sperling, Dorene M. Rentz et al. profile →
  6. Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
    2024 776 citations Oskar Hansson, José Luís Molinuevo et al. Alzheimer s & Dementia profile →
  7. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD
    2005 688 citations David H. Salat, Douglas N. Greve et al. Neurology profile →
  8. Brain Imaging in Alzheimer Disease
    2012 623 citations Reisa A. Sperling et al. profile →
  9. Alterations in Memory Networks in Mild Cognitive Impairment and Alzheimer's Disease: An Independent Component Analysis
    2006 577 citations Bradford C. Dickerson, Alireza Atri et al. Journal of Neuroscience profile →
  10. Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways
    2019 571 citations Reisa A. Sperling et al. profile →
  11. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup
    2011 554 citations Reisa A. Sperling, Bradley T. Hyman et al. Alzheimer s & Dementia profile →
  12. The Preclinical Alzheimer Cognitive Composite
    2014 543 citations Michael Donohue, Reisa A. Sperling et al. profile →
  13. The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials
    2014 531 citations Reisa A. Sperling, Elizabeth C. Mormino et al. profile →
  14. The A4 Study: Stopping AD Before Symptoms Begin?
    2014 519 citations Reisa A. Sperling, Dorene M. Rentz et al. Science Translational Medicine profile →
  15. CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology
    2013 439 citations Keith A. Johnson, Reisa A. Sperling et al. profile →
  16. Testing the Right Target and Right Drug at the Right Stage
    2011 411 citations Reisa A. Sperling et al. Science Translational Medicine profile →
  17. Implementation of subjective cognitive decline criteria in research studies
    2016 375 citations José Luís Molinuevo, Rebecca E. Amariglio et al. Alzheimer s & Dementia profile →
  18. On the path to 2025: understanding the Alzheimer’s disease continuum
    2017 369 citations John C. Morris, Reisa A. Sperling et al. Alzheimer s Research & Therapy profile →
  19. The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease
    2022 307 citations Oskar Hansson, María C. Carrillo et al. Alzheimer s & Dementia profile →
  20. Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons
    2017 307 citations Michael Donohue, Reisa A. Sperling et al. profile →
  21. Loneliness, depression and cognitive function in older U.S. adults
    2016 301 citations Nancy J. Donovan, Dorene M. Rentz et al. profile →
  22. Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals
    2020 201 citations Reisa A. Sperling, Michael Donohue et al. profile →
  23. Trial of Solanezumab in Preclinical Alzheimer’s Disease
    2023 186 citations Reisa A. Sperling, Michael Donohue et al. profile →
  24. APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease
    2024 140 citations Juan Fortea, Jordi Pegueroles et al. profile →
  25. The AHEAD 3‐45 Study: Design of a prevention trial for Alzheimer's disease
    2022 130 citations Reisa A. Sperling, Michael Donohue et al. Alzheimer s & Dementia profile →
  26. Accelerating Alzheimer’s therapeutic development: The past and future of clinical trials
    2023 103 citations Reisa A. Sperling et al. profile →
  27. Updated safety results from phase 3 lecanemab study in early Alzheimer’s disease
    2024 61 citations Lawrence S. Honig, Marwan N. Sabbagh et al. Alzheimer s Research & Therapy profile →
  28. Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease
    2025 29 citations Stephen Salloway, Reisa A. Sperling et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Reisa A. Sperling United States 104 19.6k 18.6k 15.9k 5.8k 5.7k 534 41.5k
Bruno Dubois France 83 18.9k 1.0× 15.0k 0.8× 12.7k 0.8× 6.3k 1.1× 3.4k 0.6× 419 39.4k
Eric M. Reiman United States 102 11.9k 0.6× 15.1k 0.8× 10.5k 0.7× 4.2k 0.7× 4.5k 0.8× 469 34.5k
William E. Klunk United States 83 22.3k 1.1× 24.9k 1.3× 10.1k 0.6× 6.4k 1.1× 6.9k 1.2× 342 44.3k
María C. Carrillo United States 48 20.8k 1.1× 16.4k 0.9× 8.2k 0.5× 5.9k 1.0× 3.7k 0.6× 169 36.6k
Wiesje M. van der Flier Netherlands 96 16.8k 0.9× 14.6k 0.8× 8.1k 0.5× 6.8k 1.2× 4.8k 0.8× 799 34.6k
Mark A. Mintun United States 96 12.4k 0.6× 12.3k 0.7× 20.2k 1.3× 4.2k 0.7× 9.4k 1.7× 293 43.1k
Harald Hampel Germany 98 13.9k 0.7× 17.8k 1.0× 7.8k 0.5× 6.0k 1.0× 4.5k 0.8× 496 35.3k
Sandra Weıntraub United States 78 18.5k 0.9× 11.7k 0.6× 17.2k 1.1× 4.4k 0.8× 3.2k 0.6× 305 39.2k
Hilkka Soininen Finland 105 16.1k 0.8× 16.8k 0.9× 7.7k 0.5× 6.2k 1.1× 3.1k 0.5× 680 40.6k
Yaakov Stern United States 132 30.6k 1.6× 18.1k 1.0× 17.3k 1.1× 7.4k 1.3× 3.9k 0.7× 795 67.4k

Countries citing papers authored by Reisa A. Sperling

Since Specialization
Citations

This map shows the geographic impact of Reisa A. Sperling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reisa A. Sperling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reisa A. Sperling more than expected).

Fields of papers citing papers by Reisa A. Sperling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reisa A. Sperling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reisa A. Sperling. The network helps show where Reisa A. Sperling may publish in the future.

Co-authorship network of co-authors of Reisa A. Sperling

This figure shows the co-authorship network connecting the top 25 collaborators of Reisa A. Sperling. A scholar is included among the top collaborators of Reisa A. Sperling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reisa A. Sperling. Reisa A. Sperling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Siemers, Eric, Gopalan Sethuraman, Karen Sundell, et al.. (2025). INTERCEPT-AD, a phase 1 study of intravenous sabirnetug in participants with mild cognitive impairment or mild dementia due to Alzheimer's disease. The Journal of Prevention of Alzheimer s Disease. 12(1). 100005–100005. 4 indexed citations
2.
3.
Amariglio, Rebecca E., Joshua D. Grill, Dorene M. Rentz, et al.. (2024). Longitudinal Trajectories of the Cognitive Function Index in the A4 Study. The Journal of Prevention of Alzheimer s Disease. 11(4). 838–845. 5 indexed citations
4.
Yau, Wai‐Ying Wendy, Matthew R. Scott, Rodica E. Petrea, et al.. (2024). Sex‐Specific Vulnerabilities to Subclinical Vascular Brain Injury in Early Late‐Life: The Framingham Heart Study. Annals of Neurology. 97(3). 460–469. 5 indexed citations
5.
Buckley, Rachel F., Gad A. Marshall, Patrizia Vannini, et al.. (2024). Associations Between Self and Study Partner Report of Cognitive Decline With Regional Tau in a Multicohort Study. Neurology. 102(12). e209447–e209447. 3 indexed citations
6.
Egroo, Maxime Van, Joost M. Riphagen, Nicholas J. Ashton, et al.. (2023). Ultra-high field imaging, plasma markers and autopsy data uncover a specific rostral locus coeruleus vulnerability to hyperphosphorylated tau. Molecular Psychiatry. 28(6). 2412–2422. 23 indexed citations
7.
Weizenbaum, Emma, Daniel Soberanes, Stephanie Hsieh, et al.. (2023). Capturing learning curves with the multiday Boston Remote Assessment of Neurocognitive Health (BRANCH): Feasibility, reliability, and validity.. Neuropsychology. 38(2). 198–210. 12 indexed citations
8.
Montal, Víctor, Ibai Díez, Chan Mi Kim, et al.. (2022). Network Tau spreading is vulnerable to the expression gradients of APOE and glutamatergic-related genes. Science Translational Medicine. 14(655). eabn7273–eabn7273. 28 indexed citations
9.
Scott, Matthew R., Olivia Hampton, Rachel F. Buckley, et al.. (2020). Inferior temporal tau is associated with accelerated prospective cortical thinning in clinically normal older adults. NeuroImage. 220. 116991–116991. 34 indexed citations
10.
Hanseeuw, Bernard, Jonathan Jackson, Rebecca A. Betensky, et al.. (2018). Association of anxiety with subcortical amyloidosis in cognitively normal older adults. Molecular Psychiatry. 25(10). 2599–2607. 39 indexed citations
11.
Papp, Kathryn V., et al.. (2017). Optimizing the preclinical Alzheimer's cognitive composite with semantic processing: The PACC5. Alzheimer s & Dementia Translational Research & Clinical Interventions. 3(4). 668–677. 165 indexed citations
12.
Buckley, Rachel F., Aaron P. Schultz, Trey Hedden, et al.. (2017). Functional network integrity presages cognitive decline in preclinical Alzheimer disease. Neurology. 89(1). 29–37. 72 indexed citations
13.
Molinuevo, José Luís, Jordi Camı́, Xavier Carné, et al.. (2016). Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit. Alzheimer s & Dementia. 12(5). 614–622. 41 indexed citations
14.
Rentz, Dorene M., Maria Dekhtyar, Samantha C. Burnham, et al.. (2015). THE FEASIBILITY OF AT-HOME IPAD COGNITIVE TESTING FOR USE IN CLINICAL TRIALS. The Journal of Prevention of Alzheimer s Disease. 3(1). 1–5. 46 indexed citations
15.
Shaw, Emily, Aaron P. Schultz, Reisa A. Sperling, & Trey Hedden. (2015). Functional Connectivity in Multiple Cortical Networks Is Associated with Performance Across Cognitive Domains in Older Adults. Brain Connectivity. 5(8). 505–516. 70 indexed citations
16.
Johnson, Keith A., Reisa A. Sperling, Christopher Gidicsin, et al.. (2013). Florbetapir (F18‐AV‐45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging. Alzheimer s & Dementia. 9(5S). S72–83. 190 indexed citations
17.
Sabuncu, Mert R., Randy L. Buckner, Jordan W. Smoller, et al.. (2011). The Association between a Polygenic Alzheimer Score and Cortical Thickness in Clinically Normal Subjects. Cerebral Cortex. 22(11). 2653–2661. 93 indexed citations
18.
Buckner, Randy L., Jorge Sepulcre, Tanveer Talukdar, et al.. (2009). Cortical Hubs Revealed by Intrinsic Functional Connectivity: Mapping, Assessment of Stability, and Relation to Alzheimer's Disease. Journal of Neuroscience. 29(6). 1860–1873. 2262 indexed citations breakdown →
19.
20.
Chua, Elizabeth F., Daniel L. Schacter, Erin Rand‐Giovannetti, & Reisa A. Sperling. (2007). Evidence for a specific role of the anterior hippocampal region in successful associative encoding. Hippocampus. 17(11). 1071–1080. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bruno Dubois Breakdown of academic impact, for papers by Eric M. Reiman Breakdown of academic impact, for papers by William E. Klunk Breakdown of academic impact, for papers by María C. Carrillo Breakdown of academic impact, for papers by Wiesje M. van der Flier Breakdown of academic impact, for papers by Mark A. Mintun Breakdown of academic impact, for papers by Harald Hampel Breakdown of academic impact, for papers by Sandra Weıntraub Breakdown of academic impact, for papers by Hilkka Soininen Breakdown of academic impact, for papers by Yaakov Stern
Rankless by CCL
2026